Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Kronos Bio, Inc. (KRON) had Return on Investments of -54.48% for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
-- |
|
$-133.20M |
|
-- |
|
-- |
|
$137.12M |
|
$-137.12M |
|
$3.91M |
|
$-133.20M |
|
$-133.20M |
|
$-133.20M |
|
$-133.20M |
|
$-133.20M |
|
$-133.20M |
|
$-137.12M |
|
$-135.38M |
|
56.20M |
|
56.20M |
|
$-2.37 |
|
$-2.37 |
|
| Balance Sheet Financials | |
$244.29M |
|
$12.98M |
|
$50.65M |
|
$294.94M |
|
$21.49M |
|
-- |
|
$28.95M |
|
$50.44M |
|
$244.50M |
|
$244.50M |
|
$244.50M |
|
56.97M |
|
| Cash Flow Statement Financials | |
$-90.93M |
|
$-32.22M |
|
$0.85M |
|
$200.30M |
|
$78.00M |
|
$-122.30M |
|
$31.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-91.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.48% |
|
-54.48% |
|
-45.16% |
|
|
Return on Investments |
-54.48% |
$4.29 |
|
$-1.63 |
|
$-1.62 |
|